[go: up one dir, main page]

FI873509L - Imidazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning. - Google Patents

Imidazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning. Download PDF

Info

Publication number
FI873509L
FI873509L FI873509A FI873509A FI873509L FI 873509 L FI873509 L FI 873509L FI 873509 A FI873509 A FI 873509A FI 873509 A FI873509 A FI 873509A FI 873509 L FI873509 L FI 873509L
Authority
FI
Finland
Prior art keywords
imidazolfoereningar
farmaceutisk
blandning
foerfarande foer
deras framstaellning
Prior art date
Application number
FI873509A
Other languages
English (en)
Other versions
FI873509A0 (fi
Inventor
Hisashi Takasugi
Kiyotaka Ito
Shigetaka Nishino
Akito Tanaka
Takao Takaya
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868619971A external-priority patent/GB8619971D0/en
Priority claimed from GB878715932A external-priority patent/GB8715932D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI873509A0 publication Critical patent/FI873509A0/fi
Publication of FI873509L publication Critical patent/FI873509L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI873509A 1986-08-15 1987-08-13 Imidazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning. FI873509L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868619971A GB8619971D0 (en) 1986-08-15 1986-08-15 Imidazole compounds
GB878715932A GB8715932D0 (en) 1987-07-07 1987-07-07 Imidazole compounds

Publications (2)

Publication Number Publication Date
FI873509A0 FI873509A0 (fi) 1987-08-13
FI873509L true FI873509L (fi) 1988-02-16

Family

ID=26291182

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873509A FI873509L (fi) 1986-08-15 1987-08-13 Imidazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.

Country Status (12)

Country Link
US (1) US4822805A (fi)
EP (1) EP0257897A1 (fi)
KR (1) KR880002840A (fi)
CN (1) CN87105680A (fi)
AU (1) AU7682587A (fi)
DK (1) DK425887A (fi)
FI (1) FI873509L (fi)
HU (1) HUT44779A (fi)
IL (1) IL83467A0 (fi)
NO (1) NO873432L (fi)
OA (1) OA08647A (fi)
PT (1) PT85531B (fi)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5670527A (en) * 1993-07-16 1997-09-23 Smithkline Beecham Corporation Pyridyl imidazole compounds and compositions
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US6426360B1 (en) 1994-07-28 2002-07-30 G D Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US6613789B2 (en) 1994-07-28 2003-09-02 G. D. Searle & Co. Heterocyclo-substituted imidazoles for the treatment of inflammation
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
EP0828718A1 (en) 1995-06-02 1998-03-18 G.D. SEARLE & CO. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6515014B2 (en) 1995-06-02 2003-02-04 G. D. Searle & Co. Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6512121B2 (en) 1998-09-14 2003-01-28 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5739143A (en) * 1995-06-07 1998-04-14 Smithkline Beecham Corporation Imidazole compounds and compositions
IL118544A (en) 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US6369068B1 (en) 1995-06-07 2002-04-09 Smithkline Beecham Corporation Amino substituted pyrimidine containing compounds
ZA9610687B (en) * 1995-12-22 1997-09-29 Smithkline Beecham Corp Novel synthesis.
AP9700912A0 (en) 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
ZA97175B (en) * 1996-01-11 1997-11-04 Smithkline Beecham Corp Novel substituted imidazole compounds.
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
CA2242327A1 (en) * 1996-01-11 1997-07-17 Smithkline Beecham Corporation Novel substituted imidazole compounds
WO1997035856A1 (en) * 1996-03-25 1997-10-02 Smithkline Beecham Corporation Novel treatment for cns injuries
US6677364B2 (en) * 1998-04-20 2004-01-13 G.D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
WO1998007425A1 (en) 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5929076A (en) * 1997-01-10 1999-07-27 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
JP2002504909A (ja) 1997-06-13 2002-02-12 スミスクライン・ビーチャム・コーポレイション 新規な置換ピラゾールおよびピラゾリン化合物
AU8154998A (en) 1997-06-19 1999-01-04 Smithkline Beecham Corporation Novel aryloxy substituted pyrimidine imidazole compounds
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
US6562832B1 (en) 1997-07-02 2003-05-13 Smithkline Beecham Corporation Substituted imidazole compounds
EP1019396A1 (en) 1997-07-02 2000-07-19 SmithKline Beecham Corporation Novel cycloalkyl substituted imidazoles
US7301021B2 (en) * 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
TW517055B (en) 1997-07-02 2003-01-11 Smithkline Beecham Corp Novel substituted imidazole compounds
US6489325B1 (en) 1998-07-01 2002-12-03 Smithkline Beecham Corporation Substituted imidazole compounds
WO1999001128A1 (en) * 1997-07-03 1999-01-14 Neurogen Corporation Certain diarylimidazole derivatives; a new class of npy specific ligands
JP2001518507A (ja) 1997-10-08 2001-10-16 スミスクライン・ビーチャム・コーポレイション 新規シクロアルケニル置換化合物
AR017219A1 (es) 1997-12-19 2001-08-22 Smithkline Beecham Corp Derivados de imidazol 1,4,5 sustituidos, composiciones que los comprenden, procedimiento para la preparacion de dichos derivados, uso de los derivados parala manufactura de un medicamento
JP2002516322A (ja) 1998-05-22 2002-06-04 スミスクライン・ビーチャム・コーポレイション 新規2−アルキル置換イミダゾール化合物
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
EP1112070B1 (en) * 1998-08-20 2004-05-12 Smithkline Beecham Corporation Novel substituted triazole compounds
WO2000025791A1 (en) 1998-11-04 2000-05-11 Smithkline Beecham Corporation Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6239279B1 (en) 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
DE60023025T2 (de) 1999-11-23 2006-07-13 Smithkline Beecham Corp. 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
US6759410B1 (en) * 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
US7053099B1 (en) 1999-11-23 2006-05-30 Smithkline Beecham Corporation 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
US7053098B1 (en) 1999-11-23 2006-05-30 Smithkline Beecham Corporation 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors
CZ20022100A3 (cs) 1999-12-16 2002-09-11 Schering Corporation Substituované imidazolové deriváty a farmaceutický prostředek
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
ES2372028T3 (es) * 2000-10-23 2012-01-13 Glaxosmithkline Llc Nuevo compuesto de 8h-pirido[2,3-d]pirimidin-7-ona trisustituida para el tratamiento de enfermedades mediadas por la csbp/p38 quinasa.
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6673818B2 (en) * 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
US7329401B2 (en) * 2002-04-15 2008-02-12 The Regents Of The University Of California Cyclooxygenase-2 selective agents useful as imaging probes and related methods
AU2003249977A1 (en) * 2002-07-05 2004-01-23 Axxima Pharmaceuticals Ag Imidazole compounds for the treatment of hepatitis c virus infections
AU2003263404A1 (en) * 2002-09-18 2004-04-08 Pfizer Products Inc. Novel imidazole compounds as transforming growth factor (tgf) inhibitors
PA8595001A1 (es) 2003-03-04 2004-09-28 Pfizer Prod Inc Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
EP1620406A2 (en) * 2003-05-08 2006-02-01 Astellas Pharma Inc. 1,2-diarylimidazoles useful as inhibitors of cox
MY145343A (en) 2005-03-25 2012-01-31 Glaxo Group Ltd Novel compounds
MX2007012951A (es) * 2005-03-25 2008-01-11 Glaxo Group Ltd Procedimiento para preparar derivados de pirido[2,3-d] pirimidin-7-ona y 3,4-dihidropirimidino[4,5-d]pirimidin-2(1h)-ona.
US7728027B2 (en) * 2007-08-08 2010-06-01 Bristol-Myers Squibb Company Process for synthesizing compounds useful for treating hepatitis C
NZ592297A (en) 2008-09-22 2012-11-30 Cayman Chemical Co Inc 2-Aryl-5-heteroaryl pyridine and pyrimidine derivatives as pharmaceutical active agents
WO2015144895A1 (en) * 2014-03-28 2015-10-01 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
CN106573894B (zh) * 2014-08-13 2020-10-13 日本曹达株式会社 二芳基咪唑化合物和有害生物防除剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
CH561717A5 (fi) * 1971-05-10 1975-05-15 Ciba Geigy Ag
US3929807A (en) * 1971-05-10 1975-12-30 Ciba Geigy Corp 2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
SE7601713L (sv) * 1975-03-03 1976-09-06 Merck & Co Inc Nya, substituerad imidazoler
US4440774A (en) * 1975-03-03 1984-04-03 Merck & Co., Inc. 3-Amino-2-hydroxypropoxyaryl imidazole derivatives

Also Published As

Publication number Publication date
HUT44779A (en) 1988-04-28
NO873432L (no) 1988-02-16
KR880002840A (ko) 1988-05-11
NO873432D0 (no) 1987-08-14
US4822805A (en) 1989-04-18
DK425887D0 (da) 1987-08-14
DK425887A (da) 1988-02-16
IL83467A0 (en) 1988-01-31
OA08647A (fr) 1988-11-30
PT85531A (en) 1987-09-01
AU7682587A (en) 1988-02-18
EP0257897A1 (en) 1988-03-02
FI873509A0 (fi) 1987-08-13
CN87105680A (zh) 1988-04-27
PT85531B (en) 1989-12-15

Similar Documents

Publication Publication Date Title
FI875140L (fi) Hoegabsorberande fiberflockar, foerfarande foer deras framstaellning och deras anvaendning.
FI873509L (fi) Imidazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI865369A0 (fi) N-innehaollande fusionerade heterocykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI871419A0 (fi) Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
FI871828A0 (fi) Substituerade benzamidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI874772A (fi) Fast tvaettmedelreningssammansaettning, omanvaendbar reningsdyna innehaollande densamma och foerfarande foer framstaellning.
FI860510A0 (fi) Foerfarande och anlaeggning foer roentgenfotografering av omraodet foer taenderna, kaekarna och skallen.
FI871907A0 (fi) Slitageresistent och korrosionsskyddande, keramisk kromoxidbelaeggning.
FI871719A0 (fi) Tiolaktam-n-aettiksyraderivat, deras framstaellning och anvaendning.
FI873295A (fi) Renin-haemmande di- och tripeptider, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI870450A0 (fi) Foerfarande och arrangemang foer laddning av en sluten, sekundaer elektrokemisk stroemkaella.
FI873021L (fi) Benzhydryloxietylpiperazinderivat, deras framstaellningsfoerfaranden och farmaceutiska kompositioner innehaollande dessa.
FI870342A (fi) Aminderivator, foerfarande foer deras framstaellning och deras anvaendning.
FI874548A0 (fi) Hydroxikarboxylsyraderivat, foerfarande foer deras framstaellning och deras anvaendning i tryck- eller vaermekaensliga maerkmaterial.
FI871953A0 (fi) Papperslimaemnen, deras framstaellning och anvaendning.
FI874121A0 (fi) Heterocykliska foereningar, och deras framstaellning och anvaendning.
FI874309L (fi) Salicylsyraamider, foerfarande foer deras framstaellning och deras anvaendning.
FI871813A (fi) Benzotiazenonderivat, deras framstaellningsfoerfarande och dessa innehaollande laekemedel och deras anvaendning.
FI875164A0 (fi) Hartsbelagda, icke-absorberande, kornformiga, pesticidhaltiga kompositioner och foerfarande foer deras framstaellning.
FI870696A (fi) Anordning foer snabb loesgoerning och intagning av en tross, speciellt foer oljeplattformar.
FI875509A0 (fi) Oxadiazolonderivat, foerfarande foer framstaellning daerav och herbicid innehaollande detsamma.
FI870844A0 (fi) Skogsprocessor foer faellning, kvistning och avkapning av traedstammar.
FI864766A0 (fi) Stavkonstruktion, skarvprofil och foerfarande.
FI873739L (fi) 3-brom-2,6-dimetoxibenzamider, deras framstaellning och anvaendning.
FI864085A0 (fi) Gjutform foer maskinell framstaellning av byggnadselement, isynnerhet systemelement, och gjutformssystem omfattande saodana gjutformar.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD